Page last updated: 2024-10-28

miltefosine and Necrosis

miltefosine has been researched along with Necrosis in 2 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to report a retrospective case series of anterior scleral and limbal inflammatory necrosis after adjuvant miltefosine for recalcitrant Acanthamoeba keratitis (AK)."8.12Anterior Scleral and Limbal Inflammatory Necrosis After Adjuvant Miltefosine for Recalcitrant Acanthamoeba Keratitis. ( Berdahl, J; de la Presa, M; Holland, EJ; Ibach, M, 2022)
"The purpose of this study was to report a retrospective case series of anterior scleral and limbal inflammatory necrosis after adjuvant miltefosine for recalcitrant Acanthamoeba keratitis (AK)."4.12Anterior Scleral and Limbal Inflammatory Necrosis After Adjuvant Miltefosine for Recalcitrant Acanthamoeba Keratitis. ( Berdahl, J; de la Presa, M; Holland, EJ; Ibach, M, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
de la Presa, M1
Ibach, M1
Berdahl, J1
Holland, EJ1
Gee, SN1
Rothschild, B1
Click, J1
Sheth, V1
Saavedra, A1
Hsu, MY1

Other Studies

2 other studies available for miltefosine and Necrosis

ArticleYear
Anterior Scleral and Limbal Inflammatory Necrosis After Adjuvant Miltefosine for Recalcitrant Acanthamoeba Keratitis.
    Cornea, 2022, Jun-01, Volume: 41, Issue:6

    Topics: Acanthamoeba Keratitis; Adjuvants, Immunologic; Adult; Humans; Inflammation; Necrosis; Phosphorylcho

2022
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
    Archives of dermatology, 2011, Volume: 147, Issue:7

    Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucy

2011